PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-01-20

Date Title Company
20-Jan-2026 ImmunityBio Advances Regulatory Discussions with FDA on Potential Resubmission Path for ANKTIVA® in BCG-Unresponsive Papillary Bladder Cancer Businesswire
20-Jan-2026 Brainomix e-Lung AI Imaging Technology Selected as Co-Primary Endpoint in Boehringer Ingelheim Phase 3 Clinical Trial in Pulmonary Fibrosis Brainomix
20-Jan-2026 Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney Diseases Businesswire
20-Jan-2026 Dual immunotherapy for the first line treatment of adult patients with mismatch repair deficient or microsatellite instability-high unresectable or metastatic colorectal cancer now available in Scotland Bristol Myers Squibb
20-Jan-2026 Suncombe Formalises GAMP 5 Lifecycle Delivery Across Its UK-Built GMPWasher Range Suncombe
20-Jan-2026 Exciva raises €51 million ($59m) in Series B funding round co-led by Gimv and EQT Exciva
20-Jan-2026 Medivir presenting at the Redeye Fight Cancer Event 2026 Medivir
20-Jan-2026 Vygon appoints new general manager to lead German subsidiary  Andrew Lloyd Associates
20-Jan-2026 Exciva raises €51 million ($59m) in Series B funding round co-led by Gimv and EQT Andrew Lloyd Associates
20-Jan-2026 Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection ACCESS Newswire